UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009286
Receipt number R000010896
Scientific Title A prospective study of branch duct intraductal papillary mucinous neoplasm of the pancrease; a single-center prospective study.
Date of disclosure of the study information 2012/11/09
Last modified on 2018/11/14 10:39:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective study of branch duct intraductal papillary mucinous neoplasm of the pancrease; a single-center prospective study.

Acronym

A prospective surveillance study of brunch duct IPMN.

Scientific Title

A prospective study of branch duct intraductal papillary mucinous neoplasm of the pancrease; a single-center prospective study.

Scientific Title:Acronym

A prospective surveillance study of brunch duct IPMN.

Region

Japan


Condition

Condition

Branch duct intraductal mucinous papillary neoplasm of the pancrease(BD-IPMN).

Classification by specialty

Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the natural history of BD-IPMN.

Basic objectives2

Others

Basic objectives -Others

To evaluate the incidence of carcinoma derived from BD-IPMN and ductal carcinoma concomitant with BD-IPMN.

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

The progression of BD-IPMN

Key secondary outcomes

The incidence of carcinoma derived from BD-IPMN and ductal carcinoma concomitant with BD-IPM.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients diagnosed as BD-IPMN, which has a communication with MPD detected by MRCP or EUS or ERCP.
2) Patients having fish-eye appearance of duodenal papilla or apparent mucin in pancreatic duct found in ERCP.
3) Patients over 20 years
4) Patients accepted informed consent

Key exclusion criteria

1) MPD diameter more than 10mm
2) mural nodule more than 5mm
3) pancreatic stones and dilated or stenotic MPD induced by chronic pancreatitis
4) concomitant with pancreatic ductal adenocarcinoma at the diagnosis
5) considered ineligible by attendant doctors

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Mitsuhiro Kida

Organization

Kitasato University School of Medicine

Division name

Gastroenterology

Zip code


Address

1-15-1 Kitasato Minami Sagamihara Kanagawa 252-0380 Japan

TEL

042-778-8111

Email

m-kida@kitasato-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomohisa Iwai

Organization

Kitasato University School of Medicine

Division name

Gastroenterology

Zip code


Address

1-15-1 Kitasato Minami Sagamihara Kanagawa 252-0380 Japan

TEL

042-778-8111

Homepage URL


Email

t-iwai@kitasato-u.ac.jp


Sponsor or person

Institute

Department of Gastroenterology Kitasato University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Gastroenterology Kitasato University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北里大学東病院 Kitasato University East Hospital
北里大学病院 Kitasato University Hospital


Other administrative information

Date of disclosure of the study information

2012 Year 11 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 09 Month 24 Day

Date of IRB


Anticipated trial start date

2012 Year 11 Month 01 Day

Last follow-up date

2017 Year 12 Month 01 Day

Date of closure to data entry

2018 Year 11 Month 01 Day

Date trial data considered complete

2018 Year 11 Month 01 Day

Date analysis concluded

2018 Year 11 Month 01 Day


Other

Other related information

A single-center prospective cohort study


Management information

Registered date

2012 Year 11 Month 08 Day

Last modified on

2018 Year 11 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010896


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name